The global doppler ultrasound market was valued at USD 1.69 billion in 2022 and it is predicted to surpass around USD 2.41 billion by 2032 with a CAGR of 3.63% from 2023 to 2032. The doppler ultrasound market in the United States was accounted for USD 489.4 million in 2022.
Key Pointers
Report Scope of the Doppler Ultrasound Market
Report Coverage | Details |
Revenue Share of North America in 2022 | 34.24% |
CAGR of Asia Pacific | 4.02% |
Revenue Forecast by 2032 | USD 2.41 billion |
Growth Rate from 2023 to 2032 | CAGR of 3.63% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Companies Covered | GE Healthcare; Siemens Healthineers; Koninklijke Philips N.V.; Toshiba Medical Systems Corporation; Fujifilm Holdings Corporation; Hitachi Ltd.; Esaote SpA; Samsung Medison Co., Ltd; Mindray Medical International Limited; Analogic Corporation |
The market growth is attributed to the rising technological advancements, and increasing prevalence of chronic disorders such as cancer, diabetes, chronic kidney disease, and cardiovascular disorders.
According to a study conducted by WHO, approximately 17.9 million people die every year due to cardiovascular diseases, accounting for 32% of the total deaths globally. As per the CDC, in 2019, around 26,530 deaths were caused due to AF, and it is expected to affect 12.1 million people in the U.S. by the end of 2032. Doppler ultrasound technology can detect a patient’s pulsation rhythm, which in turn, is increasing its demand in cardiovascular disease diagnosis.
Moreover, according to the National Cancer Institute, in 2022, 19,880 new cases and 12,810 deaths were reported due to ovarian cancer in the U.S. The use of Doppler ultrasound in detecting ovarian cancer, owing to its characteristics such as its non-invasiveness, convenience, and repeatability, is anticipated to fuel the demand for the market over the forecast period.
The pandemic has impacted the market negatively, owing to inconsistencies in manufacturing, supply chain disruptions, and postponements in installations. However, key players in the market, such as GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Hitachi Ltd., Esaote SpA, Samsung Medison Co., Ltd, and Analogic Corporation are driving the market growth by engaging in various strategic initiatives such as partnerships, acquisitions, new product launches, and expansions.
For instance, in September 2022, the Philips Foundation entered a cross-continental multi-year partnership with RAD-AID, a non-profit organization in the U.S. The aim of this partnership is to promote and encourage the use of diagnostic ultrasound solutions to 50 million people across Asia, Africa, Latin America, the Caribbean, and North America.
Device Type Insights
Based on device type, the market is segmented into trolley-based and handheld devices. The trolley-based segment held the largest market share of 64.12% in 2022. The growth is attributed to their extreme mobility capabilities, such as the easy transport of trolley-based Doppler ultrasound devices to various locations in a healthcare facility. Moreover, trolley-based Doppler ultrasound devices assist in rapid treatment administration, decision-making, and diagnosis, which further contributes to improved clinical outcomes.
The handheld segment is expected to advance at the fastest CAGR of 4.21% from 2023 to 2032, owing to rising awareness regarding the benefits associated with the use of handheld Doppler ultrasound devices in remote patient monitoring and home healthcare. Moreover, technological advancements in handheld Doppler ultrasound devices are further propelling market growth.
For instance, in February 2022, Koninklijke Philips N.V. announced an expansion to its ultrasound portfolio with the inclusion of Pulse Wave Doppler. The Pulse Wave Doppler ultrasound can enhance ultrasound capabilities such as advanced hemodynamic measurement and assessment on the company’s handheld ultrasound Lumify.
Application Insights
Based on application, the market is segmented into radiology, cardiology, obstetrics & gynecology, and others. The radiology segment dominated the market with a share of 25.49% in 2022. This is due to the wide application of Doppler ultrasound technology in vascular imaging to visualize and evaluate blood vessels, to diagnose and monitor conditions such as peripheral artery disease, deep vein thrombosis, and varicose veins. Moreover, Doppler ultrasound technology is also used for imaging abdominal organs to diagnose conditions such as liver diseases, gallstones, and renal cysts.
The cardiology segment is poised to advance at the fastest CAGR of 4.13% through 2032. The market growth is attributed to the rising prevalence of cardiovascular diseases globally. According to a study conducted by WHO, 17.9 million people die every year due to cardiovascular disease, which accounts for 32% of the total deaths globally. Doppler ultrasound device is widely used for diagnosing patients suffering from cardiac heart failure and hypertension. Doppler ultrasound helps determine atrioventricular cavity size, myocardial lesions, septal damage, and ventricular wall thickness.
End-use Insights
Based on end-use, the market is segmented into hospitals, diagnostic imaging centers, home care, and academic & research institutes. The hospital segment had the largest market share of 47.25% in 2022, owing to the rising adoption of Doppler ultrasound in various hospital settings, coupled with an increasing number of visits by patients suffering from lifestyle-related disorders. Moreover, rising demand for handheld Doppler ultrasound devices in OPDs and in-patient departments owing to their portable nature is driving the market.
The diagnostic imaging centers segment is expected to progress at the fastest growth of 3.82% from 2023 to 2032. The growth is attributed the rising adoption of Doppler ultrasound due to its versatility, cost-efficiency, and accuracy. Moreover, increasing government initiatives in the development of diagnostic imaging centers is propelling the market demand.
For instance, in April 2022, the UK government announced the delivery of 160 new community diagnostic centers in England by 2025. 73 diagnostic centers that have been already opened in the region have delivered around 700,000 MRI, ultrasound, CT, and endoscopy tests.
Regional Insights
North America dominated the market with a share of 34.24% in 2022, owing to the presence of key players in the region, coupled with rising government support in the form of funding and policies for technological advancements in the healthcare sector. For instance, in April 2021, Philips North America received funding of USD 11 million from the Biomedical Advanced Research and Development Authority for the development of an artificial intelligence-based ultrasound system capable of assessing COVID-19.
On the other hand, Asia Pacific is anticipated to expand at the fastest CAGR of 4.02% over the forecast period, owing to the presence of the developing healthcare sector and the increasing prevalence of chronic diseases. According to a study published by NCBI in 2022, 434.4 million people were suffering from chronic kidney disease in the region, of which almost 65 million adults have advanced stages of the disorder. Moreover, prominent players in the market are adopting various strategies such as acquisitions, product launches, and partnerships to strengthen their position.
Doppler Ultrasound Market Segmentations:
By Device Type
By Application
By End-use
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Device Type Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Doppler Ultrasound Market
5.1. COVID-19 Landscape: Doppler Ultrasound Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Doppler Ultrasound Market, By Device Type
8.1. Doppler Ultrasound Market, by Device Type, 2023-2032
8.1.1 Trolley-Based
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Handheld
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Doppler Ultrasound Market, By Application
9.1. Doppler Ultrasound Market, by Application, 2023-2032
9.1.1. Radiology
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Cardiology
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Obstetrics and Gynecology
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Doppler Ultrasound Market, By End-use
10.1. Doppler Ultrasound Market, by End-use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Diagnostic Imaging Centers
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Home Care
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Academic & Research Institutes
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Doppler Ultrasound Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Device Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 12. Company Profiles
12.1. GE Healthcare
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthineers
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Koninklijke Philips N.V.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Toshiba Medical Systems Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Fujifilm Holdings Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Hitachi Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Esaote SpA
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Samsung Medison Co., Ltd
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Mindray Medical International Limited
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Analogic Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms